💰 Dividend History

No dividend history available.

📅 Earnings & EPS History for YB

No earnings history available for this symbol.

📰 Related News & Research

• ImmunityBio Addresses FDA Concerns on Promotional Materials, Enhances Compliance Measures for ANKTIVA® 1
  April 6, 2026
  

  ImmunityBio Addresses FDA Concerns and Implements Enhanced A...

• The Buckle, Inc. 2026 Annual Report: Merchandising Strategy, Store Performance, and Cybersecurity Initiatives
  April 2, 2026
  

  The Buckle, Inc. 2025 Annual Report – Key Investor Takeaways...

• Hasbro, Inc. Files Form 8-K Reporting Cybersecurity Incident and Ongoing Investigation (April 2026)
  April 1, 2026
  

  Hasbro, Inc. Files Form 8-K: Updates on Cybersecurity Incide...

• Yangzijiang Maritime Development Ltd. EGM 2026: Share Buyback Mandate Approval, Shareholder Q&A, and Capital Management Insights
  April 1, 2026
  

  Yangzijiang Maritime Development Ltd.: EGM Approves Share Bu...

• Singapore Market Outlook April 2026: Seatrium, Yangzijiang, Manulife US REIT & Key Stock Updates – Maybank Research Insights 1
  April 1, 2026
  

  Broker: Maybank Research Pte Ltd Date of Report: 1 April 202...

• Singapore Offshore & Shipbuilding Stocks 2026: Seatrium, Yangzijiang, and Top Market News – Maybank Research Highlights
  April 1, 2026
  

  Broker Name: Maybank Research Pte Ltd Date of Report: 1 Apri...

• BOE Technology Announces 2025 Profit Distribution Plan with Cash Dividends and Share Buybacks
  April 1, 2026
  

  二、分红及回购细节披露 京东方科技集团股份有限公司（京东方A，000725/200725）董事会于2026年3...

• Skillsoft Appoints Cybersecurity CEO Art Gilliland to Board of Directors to Advance AI-Driven Workforce Transformation
  March 31, 2026
  

  Skillsoft Corp. Appoints Art Gilliland to Board of Directors...

• KeyBank and Lenders Establish Credit Agreement with Cintas Corporation – Terms, Definitions, and Financial Covenants Explained
  March 31, 2026
  

  Cintas Corporation No. 2 - Credit Agreement and Material Eve...

• ImmunityBio Secures $100 Million Financing to Accelerate Global Expansion and Advance ANKTIVA Immunotherapy Pipeline
  March 31, 2026
  

  ImmunityBio Secures \$100M Financing and Marks Global Expans...

🔍 View more Reports